Pursuant to Regulation 15(2) of SEBI(LODR), Regulation 2015. and other applicable provision as required under SEBI LODR, We are claiming Exemption under Regulation 23(9) for the Quarter ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Colinz Laboratories Ltd has filed with BSE stating that it is claiming an exemption under Regulation 23(9) of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, for a particular quarter. Regulation 23(9) typically requires listed companies to disclose details of related party transactions on a half-yearly basis along with their financial results. By citing Regulation 15(2), the company is indicating that it qualifies for certain compliance relaxations available to smaller listed entities. The filing is essentially a formal intimation to the stock exchange about this exemption claim rather than a disclosure of any business event.
This is a routine regulatory compliance filing with no material impact on the company's financials or operations. Shareholders should note that the company is not providing related party transaction details for the quarter, which is permitted under the exemption rules for eligible small-cap companies. Investors looking for transparency on related party dealings may need to rely on annual disclosures instead.